Search result for: Psoriasis Biosimilars Market

June 2026

Psoriasis Biosimilars Market Size, Share and Trends 2026 to 2035

  • Report Code : 5163
  • Published : June 2026
  • Delivery : Immediate
  • Category : Healthcare
  • No. of Pages : 150+

The global psoriasis biosimilars market size is evaluated at USD 10.46 billion in 2025 and is projected to attain around USD 29.78 billion by 2035, with a CAGR of 11.03%.

September 2026

Psoriasis Treatment Market Size, Key Companies, Company Market Share, Patient Volume, Treatment Adoption Rates, Pricing Analysis, Regulatory Landscape, Competitive Positioning, and Demand Forecast

  • Report Code : 2034
  • Published : September 2026
  • Delivery : Immediate
  • Category : Healthcare
  • No. of Pages : 150+

The global psoriasis treatment market size is expected to increase from USD 36.87 billion in 2026 and is projected to hit around USD 73.04 billion by 2035, with a CAGR of 7.9%.

September 2026

Biosimilars Market Size, Key Companies, Company Product Portfolio, Hospital Procurement Trends, Manufacturing Capacity, Sales Performance, Regulatory Approvals, Company Market Share, and Forecast

  • Report Code : 1359
  • Published : September 2026
  • Delivery : Immediate
  • Category : Healthcare
  • No. of Pages : 150+

The global biosimilars market size is exhibited at USD 47.36 billion in 2026 and is projected to hit around USD 191.29 billion by 2035, growing at a solid CAGR of 16.84%.

September 2026

Biologics and Biosimilars Market Size, Companies, Share, Patient Volume, Treatment Adoption Rates, Pricing Analysis, Regulatory Landscape, Competitive Positioning, and Demand Forecast

  • Report Code : 8097
  • Published : September 2026
  • Delivery : Immediate
  • Category : Healthcare
  • No. of Pages : 150+

The global biologics and biosimilars market size is estimated to hit around USD 2,426.85 billion by 2035 increasing from USD 700.76 billion in 2026, with a CAGR of 14.80%.

June 2026

Immunology Biosimilars Market Size, Key Companies, Company Market Share, Patient Volume, Treatment Adoption Rates, Pricing Analysis, Regulatory Landscape, Competitive Positioning, and Demand Forecast

  • Report Code : 5935
  • Published : June 2026
  • Delivery : Immediate
  • Category : Healthcare
  • No. of Pages : 150+

The global immunology biosimilars market size was estimated at USD 13.24 billion in 2026 and is expected to hit around USD 56.39 billion by 2035, growing at a CAGR of 17.51%.

For Any Query

Please drop a mail to the Precedence Research team for your queries

Contact Us

Categories

Quick Contact

call +1 650 460 3308 call +61 485 981 310
+91 87933 22019 call +44 7383 092 044 mail sales@precedenceresearch.com

Connect with us now; your solution awaits on the other side!

Contact Us